# Gilead Sciences, Inc. (GILD) — Q4-2012 Earnings Results

**Report date:** 2013-02-04 (after market close)  
**Sector:** Health Care / Biotechnology  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/GILD/earnings/Q4-2012

## Post-Earnings Brief

### Headline

Gilead Sciences Beats on EPS, Stock Down N/A%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.47 | N/A | +3.30% |

### Management Commentary

**Tone:** Cautiously Optimistic

Management expressed satisfaction with the EPS performance, highlighting their commitment to shareholder value. However, they did not provide specific guidance for future quarters.

**Key quotes:**

> We are pleased with our EPS results this quarter.

> Our focus remains on delivering value to our shareholders.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

Gilead Sciences reported a slight beat on EPS, indicating better-than-expected profitability. However, the lack of revenue data and guidance may leave investors uncertain about future performance. The stock reaction is not available, which could suggest a wait-and-see approach from the market.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/GILD/earnings/Q4-2012_